scroll to top
0
Your source for trusted research content

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "AND COVID-19 Subject OR COVID-19 pandemic Subject OR SARS-CoV-2 Subject OR SARS-CoV-2 Delta variant Subject OR SARS-CoV-2 Omicron variant Subject "

Filter
1 - 10 of 4,351 results for
 "AND COVID-19 Subject OR COVID-19 pandemic Subject OR SARS-CoV-2 Subject OR SARS-CoV-2 Delta variant Subject OR SARS-CoV-2 Omicron variant Subject "
Sort By:
Your filters
  • Publisher: taylor & francis
  • Reset filters

    • A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants.

    Publication Type: Editorial & Opinion

    Source(s): Emerging microbes & infections [Emerg Microbes Infect] 2022 Dec; Vol. 11 (1), pp. 964-967.

    Authors:

    Abstract: SARS-CoV-2 has caused the COVID-19 pandemic since early 2020. As of January 2022, the worldwide spreading of SARS-CoV-2 leads to approximately 0.35 billion of human infections and five millions of deaths. Current vaccination is one of the effective way...

    Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions.

    Publication Type: Academic Journal

    Source(s): Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Nov 30; Vol. 18 (5), pp. 2068883. Date of Electronic Publication: 2022 May 04.

    Abstract: Since commencement of COVID-19 pandemic, several SARS-CoV-2 variants have emerged amid containment efforts via vaccination. The Delta variant (B.1.617.2), discovered in October 2020, was designated as a VOC by the WHO on May 11, 2021. The enhanced tran...

    Real-world vaccine effectiveness of mRNA vaccines for SARS-CoV-2; a test-negative case-control study in a medium-sized clinic.

    Publication Type: Academic Journal

    Source(s): Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 30; Vol. 18 (7), pp. 2147353. Date of Electronic Publication: 2022 Dec 02.

    Authors:

    Abstract: Although nationwide immunization with SARS-CoV-2 mRNA vaccines began in February 2021, the evaluation of vaccine effectiveness (VE) using a test-negative design has not been conducted adequately in Japan. To evaluate the effectiveness of the SARS-CoV-2...

    SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells.

    Publication Type: Academic Journal

    Source(s): Emerging microbes & infections [Emerg Microbes Infect] 2022 Dec; Vol. 11 (1), pp. 277-283.

    Authors:

    Abstract: The novel SARS-CoV-2 Omicron variant (B.1.1.529), first found in early November 2021, has sparked considerable global concern and it has >50 mutations, many of which are known to affect transmissibility or cause immune escape. In this study, we sought ...

    Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents.

    Publication Type: Academic Journal

    Source(s): Emerging microbes & infections [Emerg Microbes Infect] 2022 Dec; Vol. 11 (1), pp. 567-572.

    Authors:

    Abstract: Global concern has been raised by the emergence and rapid transmission of the heavily mutated SARS-CoV-2 Omicron variant (B.1.1.529). So far, the infection features and immune escape ability of the Omicron variant have not been extensively studied. Her...

    Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants.

    Publication Type: Academic Journal

    Source(s): Emerging microbes & infections [Emerg Microbes Infect] 2022 Dec; Vol. 11 (1), pp. 926-937.

    Authors:

    Abstract: Pandemic influenza virus and SARS-CoV-2 vaiants have posed major global threats to public health. Broad-spectrum antivirals blocking viral entry can be an effective strategy for combating these viruses. Here, we demonstrate a frog-defensin-derived basi...

    A comparative analysis exposes an amplification delay distinctive to SARS-CoV-2 Omicron variants of clinical and public health relevance.

    Publication Type: Academic Journal

    Source(s): Emerging microbes & infections [Emerg Microbes Infect] 2023 Dec; Vol. 12 (1), pp. 2154617.

    Abstract: ABSTRACT Mutations in the SARS-CoV-2 genome may negatively impact a diagnostic test, have no effect, or turn into an opportunity for rapid molecular screening of variants. Using an in-house Emergency Use Authorized RT-qPCR-based COVID-19 diagnostic ass...

    Chapter 8 Covid-19 and the Economy of Care

    Publication Type: eBook

    Abstract: Covid-19 and the Global Political Economy investigates and explores how far and in what ways the Covid-19 pandemic is challenging, restructuring, and perhaps remaking aspects of the global political economy. Since the 1970s, neoliberal capitalism has b...

    Will Schooling Ever Change?

    Publication Type: eBook

    Abstract: This book is an insightful meta-narrative about schooling which explores the global natural experiment of the COVID-19 pandemic and its potential impact on school culture. The proposed book discusses how the abrupt and somewhat forced digital transform...

    The South African Response to COVID-19

    Publication Type: eBook

    Authors:
    • Fourie, Pieter; Lamb, Guy

    Abstract: This book analyses the first two years of South Africa’s response to the COVID-19 epidemic, from its emergence in early 2020. Drawing on the perspectives of a range of public health experts, economists and other social scientists and development practi...

    sponsored